News

FDA names former pharmaceutical company executive to oversee US drug program
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
The FDA Just Axed 52 Food Standards. Is That a Good Thing?
It noted that, at the time, there were products "that were represented as jams containing fruit, but the products contained ...
US FDA extends review of GSK's blood cancer drug
The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug Blenrep as a combination treatment, the company said on Wednesday.
FDA appoints biotech veteran George Tidmarsh to lead drug evaluation division
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
FDA appoints George Tidmarsh as top drug regulator
The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and ...
Dermatology Advisor2h
FDA Plans to Revoke 52 Food Standards
The FDA will revoke 52 food standards affecting fruit, vegetable, and dairy products deemed "obsolete and unnecessary." ...
Biotech exec George Tidmarsh picked as FDA's chief drug regulator
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
FDA to review prescription fluoride supplements for kids at risk for tooth decay
The Trump administration is inching closer to banning fluoride tablets and drops often prescribed to kids who don’t have ...
Former biotech executive appointed to lead FDA drug office
George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...
FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
Opinion
Opinion: Dietary supplements, drugs and DSHEA — preserving DSHEA’s careful balance between market access and efficacy
DSHEA struck a balance between providing easy, affordable access to dietary supplements and maintaining safety and efficacy standards for drugs.
Dr. Oz and FDA chief tout industry doing MAHA’s bidding
The Trump administration‘s “Make America Healthy Again” goals depend on negotiations with food and healthcare industry ...